Mersana Therapeutics, Inc. Annual Net Income (Loss) Attributable to Parent in USD from 2015 to 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Mersana Therapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2015 to 2023.
  • Mersana Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$24.3M, a 55.3% increase year-over-year.
  • Mersana Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$105M, a 51.3% increase year-over-year.
  • Mersana Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$172M, a 15.9% increase from 2022.
  • Mersana Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$204M, a 20.1% decline from 2021.
  • Mersana Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$170M, a 93.2% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$172M +$32.5M +15.9% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-28
2022 -$204M -$34.2M -20.1% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-28
2021 -$170M -$82M -93.2% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-28
2020 -$88M -$59.8M -212% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-28
2019 -$28.2M +$36M +56.1% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-28
2018 -$64.3M -$25.6M -66% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-26
2017 -$38.7M -$25M -183% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-28
2016 -$13.7M +$2.73M +16.6% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-08
2015 -$16.4M Jan 1, 2015 Dec 31, 2015 10-K 2018-03-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.